Clinical Trials in Heilongjiang, China
4 recruiting
Showing 1–8 of 8 trials
Recruiting
Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke
Acute Ischemic Stroke
First Affiliated Hospital of Harbin Medical University1,000 enrolled1 locationNCT07540741
Recruiting
Phase 1
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
Advanced Solid Tumors
Shanghai Pushi Medical Science Co. Ltd66 enrolled10 locationsNCT06832982
Recruiting
Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
Cutaneous Lupus Erythematosus
AstraZeneca302 enrolled272 locationsNCT06015737
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Colorectal, CancerCervical CancerLung Cancer+4 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 2
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Advanced NSCLC
Shanghai Junshi Bioscience Co., Ltd.66 enrolled18 locationsNCT06924606
Recruiting
Phase 1
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
Advanced Solid Tumor
Daiichi Sankyo210 enrolled38 locationsNCT06244485
Recruiting
Phase 2
A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma
Advanced Esophageal Squamous Cell Carcinoma
Shanghai Runshi Pharmaceutical Technology Co., Ltd138 enrolled1 locationNCT06512428
Recruiting
Chinese Psoriasis Real World Evidence Research
Psoriasis
Second Affiliated Hospital, School of Medicine, Zhejiang University10,000 enrolled29 locationsNCT04465838